Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Skin Squamous Cell Cancer × dacomitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 9 Brain Neoplasms 3 Recurrence 2 Neoplasm Metastasis 2 Head and Neck Neoplasms 2 Glioblastoma 2 Carcinoma, Squamous Cell 2 Squamous Cell Carcinoma of Head and Neck 1 Skin Squamous Cell Cancer 1 Rare Tumor 1 Penile Neoplasms 1 Non-small Cell Lung Cancer Metastatic 1 Neoplasms 1 NSCLC 1 Lung Neoplasms 1 Carcinoma 1 Advanced Gastric Cancer 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02268747 2016-07-04

Efficacy and Safety of Dacomitinib in the Treatment of Skin Squamous Cell Cancer

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown

Skin Squamous Cell Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡